GO
Loading...

Eli Lilly and Co

More

  • Final Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 6:09 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $68.37. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $51.84. Hospira fell$. 80 or 1.6 percent, to $50.08.

  • Eli Lilly adds $375M to Zymeworks partnership Wednesday, 22 Oct 2014 | 5:12 PM ET

    NEW YORK— Eli Lilly and Zymeworks said Wednesday they are expanding a cancer drug development partnership. Without explaining the initial terms of the partnership, the companies said Zymeworks could get an additional $375 million in milestones and other payments. Shares in Indianapolis- based Eli Lilly and Co. were unchanged at $64.68 on Wednesday.

  • Midday Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 1:18 PM ET

    Baxter International Inc. fell$. 24 or. 3 percent, to $68.41. Bristol-Myers Squibb Co. fell$. 01 or percent, to $51.94. Hospira rose$. 09 or. 2 percent, to $50.97.

  • Early Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 10:36 AM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $68.82. Bristol-Myers Squibb Co. rose$. 02 or percent, to $51.97. Hospira rose$. 06 or. 1 percent, to $50.94.

  • Final Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 6:01 PM ET

    Baxter International Inc. rose$. 71 or 1.0 percent, to $68.65. Bristol-Myers Squibb Co. rose $1.39 or 2.7 percent, to $51.95. Hospira rose $1.01 or 2.0 percent, to $50.88.

  • Midday Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 1:43 PM ET

    Baxter International Inc. rose$. 28 or. 4 percent, to $68.22. Bristol-Myers Squibb Co. rose$. 81 or 1.6 percent, to $51.37. Hospira rose$. 24 or. 5 percent, to $50.11.

  • Early Glance: Pharmaceuticals companies Tuesday, 21 Oct 2014 | 11:56 AM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $68.01. Bristol-Myers Squibb Co. rose$. 42 or. 8 percent, to $50.98. Hospira rose$. 22 or. 4 percent, to $50.09.

  • Final Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 6:05 PM ET

    Baxter International Inc. rose$. 70 or 1.0 percent, to $67.94. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $50.56. Hospira fell$. 20 or. 4 percent, to $49.87.

  • Midday Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 1:23 PM ET

    Baxter International Inc. rose$. 18 or. 3 percent, to $67.42. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $50.25. Hospira fell$. 18 or. 4 percent, to $49.89.

  • Early Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 10:40 AM ET

    Baxter International Inc. rose$. 02 or percent, to $67.26. Bristol-Myers Squibb Co. rose$. 03 or. 1 percent, to $50.45. Hospira rose$. 25 or. 5 percent, to $50.32.

  • Final Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 94 or 1.4 percent, to $67.24. Bristol-Myers Squibb Co. rose $1.20 or 2.4 percent, to $50.42. Hospira rose$. 40 or. 8 percent, to $50.07.

  • Midday Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 1:21 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $67.83. Bristol-Myers Squibb Co. rose $1.49 or 3.0 percent, to $50.71. Hospira rose$. 36 or. 7 percent, to $50.03.

  • Early Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 10:39 AM ET

    Baxter International Inc. fell$. 47 or. 7 percent, to $67.71. Bristol-Myers Squibb Co. rose$. 49 or 1.0 percent, to $49.71. Hospira fell$. 19 or. 4 percent, to $49.48.

  • Final Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $68.18. Bristol-Myers Squibb Co. rose$. 26 or. 5 percent, to $49.22. Hospira rose $1.55 or 3.2 percent, to $49.67.

  • Midday Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 1:21 PM ET

    Baxter International Inc. rose$. 65 or 1.0 percent, to $68.99. Bristol-Myers Squibb Co. rose$. 30 or. 6 percent, to $49.26. Hospira rose$. 61 or 1.3 percent, to $48.73.

  • Early Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 11:35 AM ET

    Baxter International Inc. fell $1.01 or 1.5 percent, to $67.33. Bristol-Myers Squibb Co. rose$. 25 or. 5 percent, to $49.21. Hospira rose$. 32 or. 7 percent, to $48.44.

  • Oct 16- The benefits of Novartis AG's anti-inflammation drug outweighed the risks in using it to treat a type of psoriasis, staff reviewers at the U.S. Food and Drug Administration said. There were no major safety issues associated with secukinumab, according to the review posted on the FDA website on Thursday- four days before a panel of outside advisers is...

  • Final Glance: Pharmaceuticals companies Wednesday, 15 Oct 2014 | 6:07 PM ET

    Baxter International Inc. fell$. 52 or. 8 percent, to $68.34. Bristol-Myers Squibb Co. rose$. 04 or. 1 percent, to $48.96. Eli Lilly& Co. fell$. 27 or. 4 percent, to $62.87.

  • Midday Glance: Pharmaceuticals companies Wednesday, 15 Oct 2014 | 1:17 PM ET

    Baxter International Inc. fell $1.69 or 2.5 percent, to $67.17. Bristol-Myers Squibb Co. fell$. 57 or 1.2 percent, to $48.35. Hospira fell $1.32 or 2.7 percent, to $47.00.

  • Early Glance: Pharmaceuticals companies Wednesday, 15 Oct 2014 | 10:46 AM ET

    Baxter International Inc. fell $1.10 or 1.6 percent, to $67.76. Bristol-Myers Squibb Co. fell$. 64 or 1.3 percent, to $48.28. Hospira fell$. 37 or. 8 percent, to $47.94.